drugset / Trial / NCT00357201

Efficacy of T1675 Versus Placebo in Patients With Bilateral Treated Moderate Dry Eye Syndrome

NCT00357201 ↗

Phase 2 Completed Laboratoires Thea
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the efficacy of a 6-month (± 14 days) dietary supplementation period with T1675, a per os omega 3 and omega 6 polyunsaturated essential fatty acid dietary formulation, versus placebo in patients with bilateral treated moderate dry eye syndrome

Timeline

Start
2004-11
Primary completion
—
Completion
2005-05

Drugs

EvaluationDrugModalityDoseRoute
Subject T1675 Unknown — Oral

Indications